An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

被引：95

作者：

Samama, Meyer Michel ^{[1
,2
]}

Amiral, Jean ^{[3
]}

Guinet, Celine ^{[1
]}

Perzborn, Elisabeth ^{[4
]}

Depasse, Francois ^{[1
]}

机构：

[1] Biomnis, Labs R&D, F-94208 Ivry, France

[2] Univ Hosp, Hotel Dieu, Paris, France

[3] HyphenBiomed, Neuville Sur Oise, France

[4] Bayer HealthCare, Wuppertal, Germany

来源：

THROMBOSIS AND HAEMOSTASIS | 2010年 / 104卷 / 05期

关键词：

PHARMACOKINETICS; PHARMACODYNAMICS; HEPARIN;

D O I：

10.1160/TH10-03-0204

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1078 / 1079

页数：2

共 9 条

[1]

ASMIS IM, 2010, HAEMOSTASCOLOGIE, V30

[2] Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti-Xa activity [J].

Depasse, F ;

Gerotziafas, GT ;

Busson, J ;

Van Dreden, P ;

Samama, MM .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (02) :346-348

[3]

HIRSH J, 1992, CHEST, V102, pS337, DOI 10.1378/chest.102.4_Supplement.337S

[4] Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor [J].

Kubitza, D ;

Becka, M ;

Voith, B ;

Zuehlsdorf, M ;

Wensing, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) :412-421

[5] Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy? [J].

Laux, Volker ;

Perzborn, Elisabeth ;

Heitmeier, Stefan ;

von Degenfeld, Georges ;

Dittrich-Wengenroth, Elke ;

Buchmueller, Anja ;

Gerdes, Christoph ;

Misselwitz, Frank .

THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) :892-899

[6] Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement [J].

Mueck, Wolfgang ;

Borris, Lars C. ;

Dahl, Ola E. ;

Haas, Sylvia ;

Huisman, MennoV. ;

Kakkar, Ajay K. ;

Kalebo, Peter ;

Muelhofer, Eva ;

Misselwitz, Frank ;

Eriksson, Bengt I. .

THROMBOSIS AND HAEMOSTASIS, 2008, 100 (03) :453-461

[7] Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor [J].

Samama, Meyer Michel ;

Martinoli, Jean-Luc ;

LeFlem, Lena ;

Guinet, Celine ;

Plu-Bureau, Genevieve ;

Depasse, Francois ;

Perzborn, Elisabeth .

THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) :815-825

[8] New oral anticoagulants in atrial fibrillation [J].

Turpie, Alexander G. G. .

EUROPEAN HEART JOURNAL, 2008, 29 (02) :155-165

[9]

Weitz JI, 2008, CHEST, V134, P473

← 1 →